These 6 Vape Brands Want to Turn Vaping into a "Health Management Tool"
Since its inception, the vaping industry has carried the mission of helping smokers quit. Over the years, this original intention has never disappeared; it has only evolved along different paths.
Today, a new wave of innovative companies is quietly emerging, no longer satisfied with being merely "harm reduction alternatives." Instead, they are deeply integrating hardware with behavioral science, artificial intelligence, clinical medicine, and even blockchain technology. They are pushing vapes to transform from "harm reduction products" into "health management tools," attempting to provide smokers with a quantifiable, trackable, and truly effective solution to nicotine addiction.
Hailing from Germany (Smokeless, nuumi), France (Kwit), the US (HabitHalo), the Netherlands (Lio), and the Web3-native project Puffpaw, these brands bring their own R&D philosophies and technologies to answer the same question: How can technology help humanity break free from nicotine dependence?
Some of these brands have official backing from the World Health Organization, others have clinical validation published in peer-reviewed journals, some have secured tens of millions of dollars in top-tier venture capital, and others are exploring a novel "quit-to-earn" incentive model. What is their actual operational status? Which ones have market validation? Which are still in early stages?
I. Overview of the 6 Brands
1. Smokeless: Design-Driven Full Closed-Loop Cessation System
Founded in 2017 near Munich, Germany, by former McKinsey strategist Marius Luther and sports scientist Valentin Götz. It has received early investment from Xpreneurs and 7percent Ventures and holds 17 patents in Europe and the US.
Initially, it focused on devices connected to an app that automatically reduced nicotine via data tracking. By 2026, the company upgraded its product line and philosophy, launching the "Smokeless XQuit" solution.
XQuit is a complete system comprising a "smart inhaler + App + pre-filled pods." Users set a 90-day quit goal. The device records usage behavior via Bluetooth, the App generates personalized behavioral interventions, and the device automatically and gradually reduces nicotine output until it reaches zero.
In 2026, XQuit won both the iF Design Award and the Red Dot Design Award, with Red Dot praising its "fascinatingly simple, calm, and fresh overall appearance," successfully boosting brand awareness. However, there are commercial concerns: the team is very small, there has been no public new funding since the 2019 seed round, and there are almost no real user reviews on mainstream channels. Its business model remains unclear.
2. nuumi: Academically Backed AI Cessation Coach
Founded in 2019 in Berlin, Germany, under Sanos Group GmbH. Its scientific team is stellar: led by a former Harvard Medical School visiting professor, paired with postdoctoral researchers in vaping cessation and psychologists. It has received €1.6 million in government grants from the EU and Investitionsbank Berlin, and completed a $328,000 equity crowdfunding round in 2023.
Its product is a "smart vape + AI coach App." The device tracks nicotine intake in real-time, while the App provides 24/7 AI behavioral training, meditation guidance, and personalized plans. The business model involves a one-time hardware fee of €69.90, plus a subscription starting at €49/month (including pods and App access), with an average customer price of €390.
In 2025, a single-arm pilot study on nuumi was published in BMC Digital Health, providing significant academic backing. Results showed that 35% of users achieved complete abstinence within the 8-week trial period, proving the potential of the solution.
Despite solid academic evidence, brand positioning is fuzzy; its App appears as a "fitness habit tracker" in the iOS store, disconnecting it from its core value of quitting. The high subscription price creates a barrier for the mass market, and shifts in the parent company's strategic focus may affect resource allocation. The scale of paying users remains undisclosed.
3. Kwit: The Global King of Pure Software Cessation
Founded in 2016 in Strasbourg, France. Total funding: €2.21 million, with investors including Pierre Fabre, AstraZeneca, and Bpifrance. Revenue in 2023 was approximately €1 million. It boasts over 5 million global users across 180 countries, with an App Store rating of 4.7.
Kwit is a pure software solution, independent of any hardware. Based on Cognitive Behavioral Therapy (CBT) combined with gamification, it breaks the quitting process into levels and milestones, offering community support. It uses a freemium model: basic features are free, while premium subscriptions unlock unlimited educational content, priority community access, and one-on-one expert consultations.
Kwit is the world's first WHO-validated quit-smoking App and is applying to become a European "Digital Medical Device." Users generally recognize its scientific basis and ease of use, but negative reviews focus on high subscription prices and frequent ads in the free version. Its future strategy is to transition towards digital therapeutics and expand into other behavioral health areas like alcohol addiction and pregnancy-related cessation.
4. HabitHalo: Physical Locking Behavioral Intervention
Founded in Indiana, USA, by Phil Tran, a heavy vape user. Investors include Boomerang Ventures and Flywheel Fund. It has completed two rounds of early-stage VC, though specific amounts are undisclosed.
Its core hardware, RipLok, is a smart locking case. Users set a maximum number of puffs per day; once exceeded, the device locks until the next day. By default, it reduces available puffs by 1% daily over 90 days to achieve gradual cessation. The companion App tracks frequency, duration, and intervals, providing real-time encouragement via the AI coach "PuffPal." Additionally, it launched the FingerHalo smart ring to monitor hand movements related to nail-biting or smoking.
The App uses a $9.99 one-time purchase model (as opposed to subscription). Hardware is in the crowdfunding stage, with the first batch shipping about 200 units and a target production of 10,000 units. The team has brought on former Eli Lilly executive Dr. Eric Beier as Chief Medical Officer.
5. Lio: Ritual Replacement with Natural Therapy
Founded in 2022 in Amsterdam, Netherlands, by siblings Mees & Vera van Lier. In March 2026, it completed a $30 million Series A round led by Andreessen Horowitz (a16z), with total funding reaching $30.5 million from 14 institutions including Y Combinator and Harry Stebbings.
Lio’s philosophy is "ritual replacement," based on research suggesting 50%-70% of addiction is behavioral ritual. The product contains no nicotine, batteries, or plastic. It is handcrafted from olive or walnut wood and contains a 100% organic essential oil core (mint, eucalyptus, etc.). When inhaled, air passes through the core, releasing only natural aromatic air—no vapor, no aerosols. Product lines include Lio Original (€29), Lio Plus (€38), and Lio Pro (€88), with daily refill costs around $1.
Over 150,000 units sold, covering 50+ countries, helping over 80,000 people quit successfully. Reviews on Trustpilot and its website are overwhelmingly positive, particularly attracting users never converted by traditional vapes. Strengths lie in its highly differentiated concept, avoiding all nicotine and chemical controversies; top VC backing and ample funding; and a natural, sustainable brand image aligned with health trends. Challenges include a lack of double-blind clinical trials to validate efficacy, relying instead on subjective user reports; and the wooden, battery-free design, while eco-friendly, offers limited functionality.
6. Puffpaw: Experimenting with the "Quit-to-Earn" Model
Founded in 2023 by Reffo (5 years in Web3) and hardware lead Jack Zheng (former Aspire Global BD Director). Total funding: $7 million, with a $6 million seed round led by Lemniscap, joined by Volt Capital, Spartan, Berachain Foundation, etc.
Its core model is "Vape-to-Earn." Smart vapes have built-in sensors that sync via Bluetooth to an App, recording puff frequency, duration, and nicotine intake in real-time, uploading this data to the Berachain blockchain. Users earn $VAPE tokens by using pods containing nicotine-free tea extract, gamifying the quitting process with social features (like device-touch interactions).
As of October 2025, company revenue reached $8 million, with monthly recurring revenue exceeding $1 million. Over 40,000 devices sold, covering most major countries.
However, it faced strong criticism in the US market for "using crypto rewards to lure users into vaping," forcing the company to modify its website wording. Furthermore, the inherent logical contradiction is that if users stop smoking, they cannot earn tokens, potentially causing the token value to collapse. From a regulatory perspective, compliance risks are extremely high due to the dual sensitivity of tobacco and cryptocurrency.
II. Horizontal Comparison: Divergent Paths, Same Goal
From a corporate fundamentals perspective, the six brands have distinct characteristics:
-
Smokeless (Germany): Hardware + App. Core tech: Automatic nicotine reduction & behavioral therapy. Seed funded (amount undisclosed). User base: Almost no public data. Business model: Unclear.
-
nuumi (Germany): Hardware + App. Core tech: AI coaching & real-time tracking. €1.6M grants + $328k crowdfunding. Users: Limited to study samples (dozens). Business model: €69.9 hardware + €49/month subscription.
-
Kwit (France): Pure software. Core tech: CBT & gamification. €2.21M funding. 5M+ users. Business model: Freemium subscription.
-
HabitHalo (USA): Hardware + App. Core tech: Physical locking & AI coaching. 2 early VC rounds (undisclosed). Hardware: Crowdfunding only (200 units). Business model: $9.99 App buyout + hardware sales.
-
Lio (Netherlands): Non-electric hardware. Core tech: Olfactory conditioning & ritual replacement. $30.5M funding. 150k+ units sold. Business model: Device + refill cores (~$1/day).
-
Puffpaw (USA): Smart hardware + App + Blockchain. Core tech: DePIN & token incentives. $7M funding. ~40k devices sold. Business model: Hardware + pods + token economy.
It is clear that these six companies are sharply divided in their technological routes and business models: Kwit bets on software scale effects; Smokeless and nuumi delve deep into German precision hardware and clinical evidence; HabitHalo specializes in physical constraints; Lio takes the alternative path of naturalism; while Puffpaw reconstructs the incentive system using encryption.
Their commonality is the attempt to break out of the traditional vape framework of "harm reduction alternatives" and head straight for the finish line of "complete cessation."
III. Industry Trends and Insights
Amidst tightening regulations (disposable bans, flavor restrictions) and rising consumer health consciousness, these new brands no longer compete on puff counts or flavors. Instead, they use quit rates, medical certifications, and behavioral science as core selling points—returning to the marketing proposition of vaping's birth.
Kwit’s pure software allows rapid user acquisition but lacks a closed loop of behavioral data. The hardware + software approach (Smokeless, nuumi, HabitHalo) enables more precise intervention but faces production and cost challenges. Meanwhile, Lio’s "anti-tech" design has surprisingly become its unique attraction.
Puffpaw demonstrates the potential of encryption technology to reshape healthy behaviors, turning users into data owners and ecosystem co-builders. However, the moral hazard and regulatory uncertainty of "quit-to-earn" make it unlikely to become mainstream in the short term.
a16z leading Lio’s $30M Series A and Lemniscap leading Puffpaw’s $6M seed round indicate that mainstream VC is eyeing the explosive potential of the tech-cessation track. In contrast, the funding lag of the two German players may cause them to miss the window.
nuumi and Kwit possess peer-reviewed papers or WHO backing, giving them a clear advantage in convincing insurance and medical institutions. Smokeless and HabitHalo currently lack high-level clinical validation, which will constrain their B2B expansion.
IV. Conclusion: The Finish Line is Not Yet in Sight, But the Race is On
The tech-cessation market in 2026 resembles a multi-lane marathon.
Smokeless and nuumi represent German-style rigor and craftsmanship but are constrained by funding and user scale bottlenecks. Kwit operates a light-asset model but must address subscription retention issues. HabitHalo found a unique entry point with physical forced locking, but the hardware path is long and arduous. Lio, with its natural rituals and top-tier VC backing, emerges as an unconventional disruptor. And Puffpaw launches a radical experiment with crypto rewards.
In the broader landscape of 2026, their biggest challenge is not competing with each other, but breaking the consumer habit surrounding vapes—for a long time, vapes have been viewed as harm-reduction trend products, not "health tools." To reverse this perception requires not just a sleek product or a few papers, but a complete businesscommercial closed-loop.